Voriconazole is a second-generation triazole antifungal medication. It's used to treat serious fungal infections, such as advanced cases of candidiasis and aspergillosis. Voriconazole effects the formation of the fungal plasma membrane by indirectly inhibiting the biosynthesis of ergosterol. This results in plasma membrane permeability changes and inhibition of growth.
Dosage: 10 mg/kg given orally once every 12 hours or 20 mg/kg given once every 24 hours.